News Archive

EMA - Human Medicines Newsletter

5th September 2024

August 2024

Read More+

FDA - Bioresearch Monitoring Technical Conformance Guide

5th September 2024

Final guidance available

Read More+

FDA - New Final Guidances Issued by Center for Veterinary Medicine

5th September 2024

CVM GFI #63 (VICH GL1) and CVM GFI #64 (VICH GL2)

Read More+

FDA - Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products

5th September 2024

Final Guidance Released

Read More+

FDA - Roundup, 30th August 2024

5th September 2024

An at-a-glance summary of news from around the agency

Read More+

FDA - Warning Letter to Italian Company

5th September 2024

The warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. 3. Your firm failed to ensure that laboratory records included complete data derived from all tests necessary to ensure compliance with established specifications and standards (21 CFR 211.194(a)).

Read More+

MHRA - Advertising Investigations

5th September 2024

Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.

Read More+

MHRA - Appointments of four MHRA Non-Executive Directors extended until 31 August 2025

5th September 2024

Extended from 1 September 2024 until 31 August 2025.

Read More+

MHRA - Consultation on Statutory Fees

5th September 2024

Proposals on ongoing cost recovery

Read More+

MHRA - Pharmacovigilance following agreement of the Windsor Framework

5th September 2024

MHRA have published information on the implementation of changes to pharmacovigilance for medicines authorised in the UK following the agreement of the Windsor Framework.

Read More+